Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Stephen Worland Insider Profile
4 Followers
Stephen Worland, Director at TRACON Pharmaceuticals, holds 0.00 shares in TRACON Pharmaceuticals (Ticker: TCON), holds 20.60K shares in GenMark (Ticker: GNMK).
Stephen Worland has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Stephen Worland holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Stephen Worland
Stephen Worland's Trading History
TRACON Pharmaceuticals
Jun 02, 2016
Director
Uninformative Buy
―
$0.00
GenMark
Jun 02, 2014
Director
Uninformative Buy
―
$266.76K
List of latest transactions for each holding click on a transaction to see Stephen Worland's performance on stock
You May Also Like
Stephen Worland insider profile FAQ
What is the percentage of profitable transactions made by Stephen Worland?
The percentage of profitable transactions made by Stephen Worland is ―.
What is the average return per transaction made by Stephen Worland?
The average return per transaction made by Stephen Worland is ―.
What stocks does Stephen Worland hold?
Stephen Worland holds: TCON, GNMK stocks.
What was Stephen Worland’s latest transaction?
Stephen Worland latest transaction was an Uninformative Buy of ―.
What was Stephen Worland's most profitable transaction?
Stephen Worland’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Stephen Worland's role in TRACON Pharmaceuticals?
Stephen Worland's role in TRACON Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.